Eli Lilly and Company
Pharmaceutical company
Based in DC
🤖
AI Overview
With $1.4M in lobbying spend across 30 quarterly filings, Eli Lilly and Company is a significant lobbying presence. They deploy 12 individual lobbyists
$1.4M
Total Lobbying Spend
30
Quarterly Filings
1
Lobbying Firms Used
12
Individual Lobbyists
Spending by Year
| Year | Lobbying Spend |
|---|---|
| 2018 | $240K |
| 2019 | $190K |
| 2020 | $70K |
| 2021 | $150K |
| 2022 | $130K |
| 2023 | $270K |
| 2024 | $200K |
| 2025 | $170K |
Lobbying Firms
VENN STRATEGIES
What They Lobby For
- General tax issues pertaining to Eli Lilly, including but not limited to tax reform.
- General Healthcare Issues pertaining to Eli Lilly and Company, including but not limited to drug pricing, importation and innovation policies.
- General Healthcare Issues pertaining to Eli Lilly and Company, including but not limited to drug pricing, importation, and innovation policies.
- Proposals on patent policy impacting biopharmaceutical innovation.
- General Healthcare issues, including drug accessibility, importation and innovation policies.
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
Who's Lobbying to Shape AI Policy
The AI regulation fight is the biggest lobbying battle of the decade.
Federal Lobbying Statistics 2025
The definitive stats — $15.2B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.